D2 Consulting’s Actionable Market Access Strategies Optimize Reimbursement for Pharmaceutical, Device and Digital Therapy Product Launches
ST. CHARLES, Mo.--(BUSINESS WIRE)--Sep 24, 2018--As payers demand value-based contracting and reimbursement, D2 Consulting empowers manufacturers with strategies and proven approaches that maximize market access opportunities and optimal reimbursement for new product launches. A leading life sciences consulting firm offering strategic and tactical commercialization services to pharmaceutical, biotechnology and medical device manufacturers, D2 implements strategies that move beyond clinical issues and discount volume pricing.
“Tackling the pressures and overcoming the challenges of launching a product in this new value-based environment requires a unique skill-set and depth of experience that few consulting organizations offer,” says Dean Erhardt, president and CEO, D2. “What sets D2 apart is our expertise in negotiating payer contracts and proven capabilities for establishing the value of a new therapy to ensure that its relevance is communicated to each stakeholder. Our team of experienced industry experts across all disciplines in managed care contracting helps clients overcome hurdles, such as payers avoiding coverage or developing discount contracts.”
By communicating the value proposition of a product and negotiating favorable coverage and reimbursement with health plans, D2 has earned the confidence of manufacturers to successfully contract with commercial, Medicaid, Medicare and Federal Government plans.
“For private equity firms investing in pharmaceutical, medical device or digital therapies, early stage companies or those launching a single product, specialized market access expertise reduces waste of investment dollars while maximizing profit opportunity,” he continues. “Our expert outsourced managed care team reduces time to access and expands market coverage while providing savings of over 40 percent versus hiring an internal team.”
He explains that a market access launch strategy requires expertise in payer negotiation and reimbursement to keep the company profitable. “For specialty high cost products, a patient support services strategy connected with the payer market access strategy is key to accelerating product success. It is important as a company to conserve margins while either scaling larger or selling to a larger organization.”
About D2 Consulting
D2 Consulting is a leading provider of commercialization services to the healthcare and life sciences industries, D2 works across all stakeholders including manufacturers, payers and channel participants to execute strategic business initiatives that ensure successful launch, distribution and reimbursement to maximize market impact and support an ongoing leadership position in the marketplace. Visit http://d2rx.com/.
View source version on businesswire.com:https://www.businesswire.com/news/home/20180924005091/en/
CONTACT: For D2 Consulting
Mary Spardel, 201.641.1911 x 22
KEYWORD: UNITED STATES NORTH AMERICA MISSOURI
INDUSTRY KEYWORD: HEALTH MEDICAL DEVICES PHARMACEUTICAL PROFESSIONAL SERVICES FINANCE INSURANCE MANAGED CARE
SOURCE: D2 Consulting
Copyright Business Wire 2018.
PUB: 09/24/2018 09:00 AM/DISC: 09/24/2018 09:01 AM